CVS HEALTH CORPORATION — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $105.69B | ↑+8.2% | $2.94B | ↑+79.0% | 2.0% |
| 2025-09-30 | $102.87B | ↑+7.8% | $-3.98B | ↓-4669.0% | -3.1% |
| 2025-06-30 | $98.92B | ↑+8.4% | $1.01B | ↓-42.7% | 2.4% |
| 2025-03-31 | $94.59B | ↑+7.0% | $1.78B | ↑+58.5% | 3.6% |
| 2024-12-31 | $97.71B | ↑+4.2% | $1.64B | ↓-19.6% | 2.4% |
| 2024-09-30 | $95.43B | ↑+6.3% | $87M | ↓-96.2% | 0.9% |
| 2024-06-30 | $91.23B | ↑+2.6% | $1.77B | ↓-7.6% | 3.3% |
| 2024-03-31 | $88.44B | ↑+3.7% | $1.12B | ↓-47.5% | 2.6% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 74 quarters
margin trajectory tells the operating-leverage storyGo deeper
CVS Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyCVS Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics